Pandemic Influenza Plan - Questar III

Section 6: Vaccine Procurement, Distribution, and Use
Pandemic Phase-Before and After a Vaccine is Available
State Health Department:
• Implement the adverse event monitoring system.
• Institute emergency regulations making pandemic vaccine adverse events
reportable.
• Collect vaccine adverse event data from LHDs and providers.
• Conduct any vaccine efficacy or adverse events studies required by CDC
or agreed upon within NYSDOH.
• Provide medical consultation for adverse events.
• Consult with CDC on adverse events as needed.
• Report all adverse events to VAERS.
• Update LHDs and providers on any new adverse events identified or any
updates on the vaccine adverse event profile.
• Conduct active surveillance for adverse events as needed.
• Provided guidance to LHDs for case investigation of adverse events.
• Implementation of IND or Emergency Use Authorization protocols if
needed.
Local Health Departments:
• Implement the adverse event monitoring system.
• Collect reports on adverse events from providers and patients, and provide
the information to the NYSDOH.
• Conduct adverse event case investigations.
• Participate in vaccine efficacy or adverse event studies as needed.
• Provide medical consultation for local adverse events.
• Update health care partners on new adverse events or updates on the
vaccine adverse event profile.
• Participate in active surveillance as needed.
• Implement IND or Emergency Use Authorization protocols if needed.
Healthcare Partners:
• Implement the adverse event monitoring system in health care facilities.
• Report all adverse events to LHD.
• Participate in adverse event case investigations.
• Provide medical consultation for vaccine adverse events in patients or
health care facilities.
• Participate in active surveillance as needed.
• Implement IND or Emergency Use Authorization protocols as needed.
February 7, 2006 6-11